学术探索
学术期刊
新闻热点
数据分析
智能评审

COMBINED ALPHA-RECEPTOR AND BETA-RECEPTOR INHIBITION IN THE TREATMENT OF HYPERTENSION

被引：28
作者：
PRICHARD, BNC [1 ]
机构：
[1] UNIV COLL HOSP LONDON, HYPERTENS CLIN, LONDON WC1E 6JJ, ENGLAND
来源：
DRUGS | 1984年 / 28卷
关键词：
D O I：
10.2165/00003495-198400282-00005
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：51 / 68
页数：18
相关论文
共 131 条
[111]   LABETALOL-INDUCED TOXIC MYOPATHY [J].
TEICHER, A ;
ROSENTHAL, T ;
KISSIN, E ;
SAROVA, I .
BRITISH MEDICAL JOURNAL, 1981, 282 (6279) :1824-1825
[112]   COMPARATIVE TRIAL OF LABETALOL AND ACEBUTOLOL, ALONE OR ASSOCIATED WITH DIHYDRALAZINE, IN TREATMENT OF ESSENTIAL-HYPERTENSION [J].
THIBONNIER, M ;
LARDOUX, MD ;
CORVOL, P .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1980, 9 (06) :561-567
[113]   MONOTHERAPY WITH LABETALOL FOR HYPERTENSIVE PATIENTS WITH NORMAL AND IMPAIRED RENAL-FUNCTION [J].
THOMPSON, FD ;
JOEKES, AM ;
HUSSEIN, MM .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 8 :S129-S133
[114]  
TRUST PM, 1976, BRIT J CLIN PHARMACO, V3, P799
[115]   COMPARISON OF LABETALOL, PROPRANOLOL AND HYDRALAZINE IN HYPERTENSIVE OUT-PATIENTS [J].
VANDERVEUR, E ;
TENBERGE, BS ;
DONKER, AJM ;
MAY, JF ;
WESSELING, H .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 21 (06) :457-460
[116]  
VANZWIETEN PA, 1982, J CARDIOVASC PHARM, V4, pS19, DOI 10.1097/00005344-198200041-00005
[117]   REVIEW OF LONG-TERM TREATMENT WITH LABETALOL [J].
WAALMANNING, HJ ;
SIMPSON, FO .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 13 :S65-S73
[118]  
WALKER JJ, 1983, POSTGRAD MED J, V59, P168
[119]  
WALSTAD RA, 1982, ACTA MED SCAND, P135
[120]   LABETALOL AND RENAL-FUNCTION [J].
WATSON, A ;
MAHER, K ;
KEOGH, JAB .
IRISH JOURNAL OF MEDICAL SCIENCE, 1981, 150 (06) :174-177
567891011121314